Anglo-Swedish drugmaker AstraZeneca says second-quarter revenue fell amid declining sales of blockbuster drugs Crestor and Seroquel XR, which lost patent protection in the United States last year
ABC News: Money, ABC News: Business
Thu, 07/27/2017 - 12:34am
Anglo-Swedish drugmaker AstraZeneca says second-quarter revenue fell amid declining sales of blockbuster drugs Crestor and Seroquel XR, which lost patent protection in the United States last year